Genelux Co. (NASDAQ: GNLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Genelux Co. (NASDAQ: GNLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Genelux prices 3M shares at $3.50 in underwritten public offering [Seeking Alpha]
Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock